ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in India
Dr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The partnership includes marketing rights for Nepal and addresses the high mortality rate in traumatic haemorrhages.
Announcement as on 22 March 2024

Dr Reddy's, Pharmazz ink licence pact to commercialise resuscitative agent
With this agreement, India will become the first global territory where Centhaquin (Lyfaquin) is being launched immediately, according to the company
Announcement as on 22 March 2024

Dr Reddy's Labs launches Versavo drug in UK
Dr Reddy's Laboratories said that it has launched Versavo in the United Kingdom (UK) for the treatment of several types of cancers.
Announcement as on 19 March 2024

Market Trading Guide: Tech Mahindra, Dr Reddy's Laboratories among 4 stock recommendations for Wednesday
The S&P BSE Sensex closed 1% lower at 72,012, while the NSE Nifty50 index ended below the 21,850 level.
Announcement as on 19 March 2024

Dr Reddy's gets Rs 74.22 cr tax demand from GST authority
Pharma major Dr Reddy's Laboratories Ltd received a tax demand with penalty of over Rs 74.22 crore from GST authority for wrongly availing credit of input tax. The company will file an appeal with the appellate authority in response to a regulatory filing.
Announcement as on 12 March 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.62
  • 12Day Average: 14.25
  • 20Day Average: 13.87
  • 50Day Average: 13.62
  • 100Day Average: 13.75
  • 150Day Average: 13.77
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.27, 13.96, 0.26
Indicator MACD is in positive zone

Indicator ADX (14)

3.45, 37.5, 35
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.61 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 0.99 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 0.94 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.48 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.03 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.28 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.87 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.15 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.9 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.56 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 0.8 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.45 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top